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757Heart Association functional class and low stroke
rates (3.1% vs. 2.2%; p ¼ 0.11).
The FRANCE 2 registry reported more frequent use
of post-procedural pacemaker implantation in men
(3), while more women had higher rates with the
balloon-expandable valve (Sapien, Edwards Life-
sciences, Irvine, California), which may illustrate the
impact of balloon expansion in smaller aortic roots.
After multiple adjustments, we found the male
sex to be a predictive factor of 1-month to 1-year
mortality. Our report is the ﬁrst large study to
corroborate such insight of the literature (2,3).
Although aortic stenosis affects both sexes equally
(4), the limited use of TAVR in female patients
(“only” 49.5% of the cohort) is somewhat confusing,
given their naturally longer life expectancy. This
paradox had already been conﬁrmed in valvular sur-
gery (5). Women should, in fact, receive a higher rate
of TAVR procedures, which could further enhance its
cost-effectiveness.
In conclusion, our study provides evidence of the
numerous imbalances in baseline characteristics and
outcomes that exist between sexes. The lower 1-year
mortality in women remained signiﬁcant after
adjustment for confounders. The logistic EuroSCORE
was not a good predictor of mortality and appeared
unsuitable for 1-month prognosis estimation in fe-
male patients. This underlines the usefulness of
drawing up a speciﬁc risk score for complications
and mortality in TAVR patients, notably one that
includes sex.*Loïc Bière, MD
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by Dr. Fuster (1), which emphasizes that technological
advances are replacing medicine at the patient’s
bedside, instead of complementing it.
In 1964, Herbert Marcuse published a book that
became famous in the student movement of the 1960s:
One-Dimensional Man (2). According to the author,
modern society tends to control, suppress, or even
eliminate many aspects of human existence, such as
nature, art, or sexuality. In our technological civiliza-
tionman lives predominantly in 1 dimension, based on
production and consumption of waste, without the
possibility of resistance. The current diagnostic and
therapeutic approach, based largely on technology at
the expense of the enormous amount of information
and its effects that can result from personal interac-
tion between doctor and patient, leads us to believe
that patients are currently conﬁned to a single
dimension—that of medicine itself. Other dimensions
that play a signiﬁcant role in the pathogenesis and
prognosis of diseases, such as the psychological, so-
cial, economic, or spiritual, are in fact ignored.
It is clear that patients with myocardial infarction
show an increased prevalence of stress at work, in the
family, ﬁnancial stress, and stressful life events
compared with healthy controls (3). It is also clear that
depression increases the risk of developing ischemic
heart disease in previously healthy persons and is
associated with increased mortality after myocardial
infarction, although this relationship is attenuated—
but remains signiﬁcant—after adjusting for the
severity of the heart disease and other variables.
Anxiety in young people predicts subsequent cardio-
vascular events and worsens the prognosis in patients
with ischemic heart disease. More recently it has been
shown that acute emotional triggers, such as anger
attacks, can precipitate a myocardial infarction, an
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758ischemic or hemorrhagic stroke, or a ventricular
arrhythmia (4). Social factors such as isolation and
lack of human support also affect the incidence of
cardiovascular disease. The economically less well-off
classes are at a disadvantage regarding many diseases,
including cancer and cardiovascular disease. And
ﬁnally, it has been proved that even spiritual factors,
such as religiosity, not only are able to inﬂuence how
the patient faces and tolerates the disease, but also are
associated with prolonged survival (5).
A medicine that is essentially technological fails to
take into consideration the personal aspect, namely
how the patient lives with his or her illness. The impact
of a disease on family, work, sexual, and emotional life
as well as the patient’s self-image is not explored in
present-daymedicine, and doctors often totally ignore
the personal dimension of their patients. Medicine is
certainly very complex, and technology helps us shed
light into this abyss for better patient care, but the
patient is even more complex. However, we should
consider many more variables than we usually do.
Finally, the integration of medicine at the bedside and
technology could reduce the number of inappropriate
examinations, and thus healthcare costs.
For Marcuse, man had to break free from the con-
straints of a technological civilization to achieve
freedom, and this freedom would have to be achieved
mostly through the imagination (l’imagination au
pouvoir). Unfortunately, the patient cannot free
himself or herself alone from the dimension to which
he or she has been relegated; this is the duty of
physicians. As suggested by Dr. Fuster, without
sacriﬁcing our technological progress, physicians
must rediscover the human dimension of patients,
their fragility faced with the disease and their anxi-
eties; they should spend more time communicating
with their patients, resume the habit of performing a
physical examination as complete as possible, better
understand nonverbal body language, and, ﬁnally,
consider themselves an integral part of the cure.*Daniele Rovai, MD
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1158–63.Characteristic LV Regional
Wall Motion Abnormality
Sign of Cardiotoxicity?I read with interest the State-of-the-Art Paper by
Thavendiranathan et al. (1).
I would like to ask the authors if they have noticed
characteristic regional wall motion pattern in dilated
cardiomyopathy-inferoposterior akinesia with pre-
served contractility in proximal third of the posterior
wall, together with various degree of hypocon-
tractility in the remaining left ventricle. It would be of
interest to answer when this pattern occurs in the
course of cardiomyopathy development and if it is
preceded by inferior wall hypokinesis. What is the
recovery potential if chemotherapy is stopped and
cardioprotective medications instituted immediately
after the recognition of these simple and quickly
acquirable parameters?*Niksa Drinkovic, Jr, MD
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